On Tuesday, GE HealthCare Technologies Inc (NASDAQ: GEHC) opened lower -3.57% from the last session, before settling in for the closing price of $81.75. Price fluctuations for GEHC have ranged from $57.65 to $94.80 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 5.31% over the last five years. Company’s average yearly earnings per share was noted 1.32% at the time writing. With a float of $454.26 million, this company’s outstanding shares have now reached $455.51 million.
GE HealthCare Technologies Inc (GEHC) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of GE HealthCare Technologies Inc is 0.28%, while institutional ownership is 85.77%. The most recent insider transaction that took place on Nov 24 ’25, was worth 353,045. Before that another transaction happened on Oct 27 ’25, when Company’s Former Officer proposed sale 4,585 for $78.95, making the entire transaction worth $361,993.
GE HealthCare Technologies Inc (GEHC) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 1.45 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 1.26) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.19% during the next five years compared to 5.31% growth over the previous five years of trading.
GE HealthCare Technologies Inc (NASDAQ: GEHC) Trading Performance Indicators
Check out the current performance indicators for GE HealthCare Technologies Inc (GEHC). In the past quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.77. Likewise, its price to free cash flow for the trailing twelve months is 25.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.84, a number that is poised to hit 1.40 in the next quarter and is forecasted to reach 4.94 in one year’s time.
